James Lopez

Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma

Meera Mohan, Samantha Kendrick, Anikó Szabó et al. · Blood Advances · 2021 · 41 citations · Full text

Medicine, Hematology, Oncology +17

A phase I/II study of dovitinib (TKI258), a FGFR and VEGFR inhibitor, in patients (pts) with advanced or metastatic renal cell cancer: Phase I results.

Eric Angevin, Chieh‐Yu Lin, A. U. Pande et al. · Journal of Clinical Oncology · 2010 · 23 citations

Medicine, Oncology, Pharmacology +15

TKI258 (dovitinib lactate) in metastatic renal cell carcinoma (mRCC) patients refractory to approved targeted therapies: A phase I/II dose finding and biomarker study

Eric Angevin, James Lopez, A. U. Pande et al. · Journal of Clinical Oncology · 2009 · 22 citations

Medicine, Oncology, Pharmacology +17

Two Cases of Vancomycin-Resistant Enterococcus faecium Bacteremia With Development of Daptomycin-Resistant Phenotype and its Detection Using Oxford Nanopore Sequencing

Zulema Udaondo, Piroon Jenjaroenpun, Thidathip Wongsurawat et al. · Open Forum Infectious Diseases · 2020 · 16 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17